Madhu J. John

3.1k total citations · 1 hit paper
44 papers, 2.4k citations indexed

About

Madhu J. John is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Madhu J. John has authored 44 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 23 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Madhu J. John's work include Colorectal and Anal Carcinomas (14 papers), Gastric Cancer Management and Outcomes (9 papers) and Esophageal Cancer Research and Treatment (8 papers). Madhu J. John is often cited by papers focused on Colorectal and Anal Carcinomas (14 papers), Gastric Cancer Management and Outcomes (9 papers) and Esophageal Cancer Research and Treatment (8 papers). Madhu J. John collaborates with scholars based in United States, India and Puerto Rico. Madhu J. John's co-authors include Miljenko V. Pilepich, C.A. Lawton, William T. Sause, Marshall S. Flam, David J. Grignon, Phillip Rubin, J Mesić, Mitchell Machtay, Kathryn Winter and Marvin Rotman and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Madhu J. John

44 papers receiving 2.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

2001 594 citations Miljenko V. Pilepich, Kathryn Winter et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Madhu J. John United States	25	1.7k	1.1k	375	338	197	44	2.4k
R. L. Scotte Doggett United States	20	864 0.5×	440 0.4×	239 0.6×	297 0.9×	57 0.3×	26	1.3k
J Mesić United States	9	1.5k 0.9×	432 0.4×	404 1.1×	298 0.9×	39 0.2×	13	1.9k
O. Kenneth Macdonald United States	23	710 0.4×	442 0.4×	330 0.9×	367 1.1×	279 1.4×	40	1.6k
J. Bernier Switzerland	24	922 0.5×	899 0.8×	348 0.9×	736 2.2×	50 0.3×	59	2.2k
Kinji Nishiyama Japan	22	727 0.4×	768 0.7×	282 0.8×	521 1.5×	202 1.0×	63	1.6k
D. Jeffrey Demanes United States	25	1.5k 0.9×	747 0.7×	1.3k 3.4×	260 0.8×	811 4.1×	95	2.9k
B. Chauvet France	24	1.1k 0.6×	602 0.5×	652 1.7×	356 1.1×	57 0.3×	97	1.9k
B. Esche Canada	17	994 0.6×	403 0.4×	615 1.6×	229 0.7×	143 0.7×	32	1.5k
Toru Harabayashi Japan	20	661 0.4×	632 0.6×	340 0.9×	264 0.8×	36 0.2×	61	1.5k
Ferrán Guedea Spain	20	1.0k 0.6×	416 0.4×	699 1.9×	411 1.2×	150 0.8×	102	2.1k

Countries citing papers authored by Madhu J. John

Since Specialization

Citations

This map shows the geographic impact of Madhu J. John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madhu J. John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madhu J. John more than expected).

Fields of papers citing papers by Madhu J. John

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madhu J. John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madhu J. John. The network helps show where Madhu J. John may publish in the future.

Co-authorship network of co-authors of Madhu J. John

This figure shows the co-authorship network connecting the top 25 collaborators of Madhu J. John. A scholar is included among the top collaborators of Madhu J. John based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madhu J. John. Madhu J. John is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Konski, André, M. López García, Madhu J. John, et al.. (2008). Evaluation of Planned Treatment Breaks During Radiation Therapy for Anal Cancer: Update of RTOG 92-08. International Journal of Radiation Oncology*Biology*Physics. 72(1). 114–118. 82 indexed citations

Suntharalingam, Mohan, Jennifer Moughan, Lawrence R. Coia, et al.. (2005). Outcome Results of the 1996-1999 Patterns of Care Survey of the National Practice for Patients Receiving Radiation Therapy for Carcinoma of the Esophagus. Journal of Clinical Oncology. 23(10). 2325–2331. 36 indexed citations

Suntharalingam, Mohan, Jennifer Moughan, Lawrence R. Coia, et al.. (2003). The national practice for patients receiving radiation therapy for carcinoma of the esophagus: Results of the 1996–1999 Patterns of Care Study. International Journal of Radiation Oncology*Biology*Physics. 56(4). 981–987. 69 indexed citations

Pilepich, Miljenko V., Kathryn Winter, Madhu J. John, et al.. (2001). Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. International Journal of Radiation Oncology*Biology*Physics. 50(5). 1243–1252. 594 indexed citations breakdown →

Coia, Lawrence R., Bruce D. Minsky, Madhu J. John, et al.. (1999). The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus. Cancer. 85(12). 2499–2505. 44 indexed citations

John, Madhu J., et al.. (1997). 136 Dose escalation without split-course chemoradiation for anal cancer: Results of a phase II RTOG study. International Journal of Radiation Oncology*Biology*Physics. 39(2). 203–203. 14 indexed citations

Emami, Bahman, Charles L. Scott, Roger W. Byhardt, et al.. (1996). 102 The value of regional nodal radiotherapy (dose/volume) in the treatment of unresectable non-small cell lung cancer: An RTOG analysis. International Journal of Radiation Oncology*Biology*Physics. 36(1). 209–209. 10 indexed citations

Pilepich, Miljenko V., William T. Sause, William U. Shipley, et al.. (1995). Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group. Urology. 45(4). 616–623. 393 indexed citations

Pilepich, Miljenko V., Jan W. Buzydlowski, Madhu J. John, et al.. (1995). Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: Outcome results of RTOG 83-07. International Journal of Radiation Oncology*Biology*Physics. 32(1). 175–180. 24 indexed citations

10.

Pilepich, M.V., et al.. (1990). Phase II Radiation Therapy Oncology Group Study of Hormonal Cytoreduction with Flutamide and Zoladex in Locally Advanced Carcinoma of the Prostate Treated with Definitive Radiotherapy. American Journal of Clinical Oncology. 13(6). 461–464. 21 indexed citations

11.

John, Madhu J., et al.. (1989). Radiotherapy alone and chemoradiation for nonmetastatic. Cancer. 63(12). 2397–2403. 99 indexed citations

12.

Chen, Karl T. K., Marshall S. Flam, Cynthia J. Curry, & Madhu J. John. (1989). Hodgkinʼs Disease Complicating Neuronal Ceroid-Lipofuscinosis. Journal of Pediatric Hematology/Oncology. 11(1). 51–54. 1 indexed citations

13.

Pilepich, Miljenko V., John M. Krall, Madhu J. John, et al.. (1989). Hormonal cytoreduction in locally advanced carcinoma of the prostate treated with definitive radiotherapy: Preliminary results of RTOG 83-07. International Journal of Radiation Oncology*Biology*Physics. 16(3). 813–817. 39 indexed citations

14.

John, Madhu J., et al.. (1987). Inoperable Esophageal Carcinoma. American Journal of Clinical Oncology. 10(4). 310–316. 12 indexed citations

15.

Flam, Marshall S., et al.. (1987). Definitive combined modality therapy of carcinoma of the anus. Diseases of the Colon & Rectum. 30(7). 495–502. 66 indexed citations

16.

Flam, Marshall S., et al.. (1983). Definitive nonsurgical therapy of epithelial malignancies of the anal canal a report of 12 cases. Cancer. 51(8). 1378–1387. 41 indexed citations

17.

Rotman, Marvin, Madhu J. John, Kwang Nam Choi, et al.. (1979). Limitations of adjunctive surgery in carcinoma of the cervix. International Journal of Radiation Oncology*Biology*Physics. 5(3). 327–332. 42 indexed citations

18.

Rotman, Marvin, et al.. (1978). Extended field para-aortic radiation in cervical carcinoma: The case for prophylactic treatmentt. International Journal of Radiation Oncology*Biology*Physics. 4(9-10). 795–799. 38 indexed citations

19.

John, Madhu J., et al.. (1978). The intracavitary applicator in relation to complications of pelvic radiation—the ernst system. International Journal of Radiation Oncology*Biology*Physics. 4(11-12). 951–956. 8 indexed citations

20.

John, Madhu J., William Cham, Norma Wollner, et al.. (1976). Endodermal Sinus Tumors of the Ovary in Children. Radiology. 121(1). 177–181. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact